SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 80 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $373,576 | +28.0% | 389,142 | 0.0% | 0.00% | – |
Q1 2023 | $291,857 | +103.5% | 389,142 | 0.0% | 0.00% | – |
Q4 2022 | $143,399 | -14.1% | 389,142 | 0.0% | 0.00% | – |
Q3 2022 | $167,000 | -45.1% | 389,142 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $304,000 | +30300.0% | 389,142 | +62162.7% | 0.00% | – |
Q3 2021 | $1,000 | -75.0% | 625 | -38.2% | 0.00% | – |
Q2 2021 | $4,000 | +100.0% | 1,011 | +1.3% | 0.00% | – |
Q1 2020 | $2,000 | – | 998 | +1591.5% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 59 | -80.4% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 301 | +1.0% | 0.00% | – |
Q2 2019 | $3,000 | +200.0% | 298 | +144.3% | 0.00% | – |
Q1 2019 | $1,000 | -90.9% | 122 | -90.4% | 0.00% | – |
Q4 2018 | $11,000 | -63.3% | 1,273 | -29.7% | 0.00% | – |
Q3 2018 | $30,000 | -54.5% | 1,810 | -42.7% | 0.00% | – |
Q2 2018 | $66,000 | +73.7% | 3,161 | +33.9% | 0.00% | – |
Q1 2018 | $38,000 | – | 2,361 | +5032.6% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 46 | -93.0% | 0.00% | – |
Q2 2013 | $5,000 | – | 661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |